BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Gastric cancer AND FHIT, P49789, FRA3B, AP3Aase, ENSG00000189283, 2272 AND Prognosis
19 results:

  • 1. Noninvasive imaging of the tumor immune microenvironment correlates with response to immunotherapy in gastric cancer.
    Huang W; Jiang Y; Xiong W; Sun Z; Chen C; Yuan Q; Zhou K; Han Z; Feng H; Chen H; Liang X; Yu S; Hu Y; Yu J; Chen Y; Zhao L; Liu H; Zhou Z; Wang W; Wang W; Xu Y; Li G
    Nat Commun; 2022 Aug; 13(1):5095. PubMed ID: 36042205
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis.
    Bria E; Pilotto S; Simbolo M; Fassan M; de Manzoni G; Carbognin L; Sperduti I; Brunelli M; Cataldo I; Tomezzoli A; Mafficini A; Turri G; Karachaliou N; Rosell R; Tortora G; Scarpa A
    Sci Rep; 2016 Mar; 6():22982. PubMed ID: 26961069
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Aberrant gene promoter methylation of p16, fhit, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
    He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
    Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Abnormal fhit protein expression may be correlated with poor prognosis in gastric cancer: a meta-analysis.
    Wang HL; Zhou PY; Liu P; Zhang Y
    Tumour Biol; 2014 Jul; 35(7):6815-21. PubMed ID: 24729090
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The pathobiological behaviors and prognosis associated with Japanese gastric adenocarcinomas of pure WHO histological subtypes.
    Zheng HC; Zheng YS; Xia P; Xu XY; Xing YN; Takahashi H; Guan YF; Takano Y
    Histol Histopathol; 2010 Apr; 25(4):445-52. PubMed ID: 20183797
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Expressions of cyclinB1, fhit and Ki-67 in 336 gastric carcinoma patients and their clinicopathologic significance].
    Li YZ; Zhao P
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(33):2337-41. PubMed ID: 20095356
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Comparative analysis of DNA methylation between primary and metastatic gastric carcinoma.
    Kim JH; Jung EJ; Lee HS; Kim MA; Kim WH
    Oncol Rep; 2009 May; 21(5):1251-9. PubMed ID: 19360301
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comparative analysis of protein expressions in primary and metastatic gastric carcinomas.
    Kim JH; Kim MA; Lee HS; Kim WH
    Hum Pathol; 2009 Mar; 40(3):314-22. PubMed ID: 18835621
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Low expression of fhit and PTEN correlates with malignancy of gastric carcinomas: tissue-array findings.
    Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y
    Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):432-40. PubMed ID: 18091387
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Promoter hypermethylation of CDH1, fhit, MTAP and PLAGL1 in gastric adenocarcinoma in individuals from Northern Brazil.
    Leal M; Lima E; Silva P; Assumpção P; Calcagno D; Payão S; Burbano RR; Smith M
    World J Gastroenterol; 2007 May; 13(18):2568-74. PubMed ID: 17552003
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pathobiological characteristics of intestinal and diffuse-type gastric carcinoma in Japan: an immunostaining study on the tissue microarray.
    Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Miwa S; Tsuneyama K; Takano Y
    J Clin Pathol; 2007 Mar; 60(3):273-7. PubMed ID: 16714395
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinicopathological significance of fhit protein expression in gastric adenocarcinoma patients.
    Zhao P; Liu W; Lu YL
    World J Gastroenterol; 2005 Sep; 11(36):5735-8. PubMed ID: 16237777
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Epstein-barr virus-positive gastric carcinoma has a distinct protein expression profile in comparison with epstein-barr virus-negative carcinoma.
    Lee HS; Chang MS; Yang HK; Lee BL; Kim WH
    Clin Cancer Res; 2004 Mar; 10(5):1698-705. PubMed ID: 15014022
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Tumour suppressor gene expression correlates with gastric cancer prognosis.
    Lee HS; Lee HK; Kim HS; Yang HK; Kim WH
    J Pathol; 2003 May; 200(1):39-46. PubMed ID: 12692839
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Preferential loss of fhit expression in signet-ring cell and Krukenberg subtypes of gastric cancer.
    Chang YT; Wu MS; Chang CJ; Huang PH; Hsu SM; Lin JT
    Lab Invest; 2002 Sep; 82(9):1201-8. PubMed ID: 12218081
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Occurrence and prognostic implications of micrometastases in lymph nodes from patients with submucosal gastric carcinoma.
    Choi HJ; Kim YK; Kim YH; Kim SS; Hong SH
    Ann Surg Oncol; 2002; 9(1):13-9. PubMed ID: 11829425
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. fhit expression in gastric adenocarcinoma: correlation with disease stage and survival.
    Capuzzi D; Santoro E; Hauck WW; Kovatich AJ; Rosato FE; Baffa R; Huebner K; McCue PA
    Cancer; 2000 Jan; 88(1):24-34. PubMed ID: 10618602
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. fhit gene in gastric cancer: association with tumour progression and prognosis.
    Noguchi T; Müller W; Wirtz HC; Willers R; Gabbert HE
    J Pathol; 1999 Aug; 188(4):378-81. PubMed ID: 10440747
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
    van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
    Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.